DBpedia – Linked Data Fragments

Matches in DBpedia 2015-10 for { ?s ?p "Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer's disease. Mike Mullan's Alzheimer research is well known among the Biomedical Community. Dr. Mullan's Alzheimer research work resulted in identifying the most widely known Swedish Mutation that is present in familial form. Transgenic Animal models for Alzheimer Disease frequently use the Swedish Mutation.Dr. Mullan is a recognized authority on Alzheimer's disease and related disorders. Dr. Michael Mullan was trained as a physician in England receiving his medical degree from London University. He subsequently gained a PhD in molecular genetics, also from London University. He is an inventor on the patents covering the first ever genetic mutations linked to familial Alzheimer's disease. He was an author and senior author on the first papers describing the genetic errors which cause early onset familial Alzheimer's disease. He has co-authored over 200 papers on Alzheimer's disease and related disorders—on many of which he served as senior author. He has held positions a Professorial Chair and positions as professor of Psychiatry, Neurology, and Pathology. He help positions at The Roskamp Institute in the past as the Director and CEO. The institute is funded by multiple agencies, including the NIH and the Department of Defense.Dr. Michael Mullan along with a team of neuroscientists at the Roskamp Institute invented the Brain Reserve Index, a numerical index that indicates risk of developing Alzheimer's Disease. Dr. Mike Mullan is the founder of the Roskamp Institute in Sarasota, Florida. Under Dr. Michael Mullan's leadership the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder. He has published over 200 research papers.Dr. Michael Mullan is currently the CEO and chairman of the Board for Rockcreek Pharmaceuticals. Dr. Mullan has served in numerous directorship positions for medical research organizations, including the Roskamp Institute from 2003 to 2011, Roskamp Institute for Research of Alzheimer’s Disease and related Neuropsychiatric Disorders from 1998 to 2003, and the Memory Disorder Clinic from 1998 to 2003. Dr. Mullan taught as a professor of medicine in neuroscience, psychiatry and pathology at the University of South Florida from 1995 to 2003. Dr. Mullan has authored or co-authored more than 200 articles on an array of medical topics, including the treatment of Alzheimer’s disease. Dr. Mullan received his medical degree, MBBS (M.D.), and Ph.D. in Molecular Genetics from London University."@en }

• Michael_Mullan abstract "Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer's disease. Mike Mullan's Alzheimer research is well known among the Biomedical Community. Dr. Mullan's Alzheimer research work resulted in identifying the most widely known Swedish Mutation that is present in familial form. Transgenic Animal models for Alzheimer Disease frequently use the Swedish Mutation.Dr. Mullan is a recognized authority on Alzheimer's disease and related disorders. Dr. Michael Mullan was trained as a physician in England receiving his medical degree from London University. He subsequently gained a PhD in molecular genetics, also from London University. He is an inventor on the patents covering the first ever genetic mutations linked to familial Alzheimer's disease. He was an author and senior author on the first papers describing the genetic errors which cause early onset familial Alzheimer's disease. He has co-authored over 200 papers on Alzheimer's disease and related disorders—on many of which he served as senior author. He has held positions a Professorial Chair and positions as professor of Psychiatry, Neurology, and Pathology. He help positions at The Roskamp Institute in the past as the Director and CEO. The institute is funded by multiple agencies, including the NIH and the Department of Defense.Dr. Michael Mullan along with a team of neuroscientists at the Roskamp Institute invented the Brain Reserve Index, a numerical index that indicates risk of developing Alzheimer's Disease. Dr. Mike Mullan is the founder of the Roskamp Institute in Sarasota, Florida. Under Dr. Michael Mullan's leadership the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder. He has published over 200 research papers.Dr. Michael Mullan is currently the CEO and chairman of the Board for Rockcreek Pharmaceuticals. Dr. Mullan has served in numerous directorship positions for medical research organizations, including the Roskamp Institute from 2003 to 2011, Roskamp Institute for Research of Alzheimer’s Disease and related Neuropsychiatric Disorders from 1998 to 2003, and the Memory Disorder Clinic from 1998 to 2003. Dr. Mullan taught as a professor of medicine in neuroscience, psychiatry and pathology at the University of South Florida from 1995 to 2003. Dr. Mullan has authored or co-authored more than 200 articles on an array of medical topics, including the treatment of Alzheimer’s disease. Dr. Mullan received his medical degree, MBBS (M.D.), and Ph.D. in Molecular Genetics from London University.".